Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2

计划入组 400 人 · 首次发布于 2025 年 7 月 31 日

Virtual Reality Prolonged Exposure (PE) for Bus Bomb Survivors

计划入组 5 人 · 首次发布于 2007 年 5 月 16 日

Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study

计划入组 3,000 人 · 首次发布于 2025 年 7 月 31 日

BMB-101

BMB-xxx

BMB-72

HIROSHIMA RED CROSS HOSPITAL & ATOMIC-BOMB SURVIVORS HOSPITAL

Japan

Reitter Corp.

United States

Ritter Pharmaceuticals, Inc.

United States

Canopy Growth Expands German Medical Cannabis Portfolio with Tweed Brand Launch

US Secures Cobalt-60 Removed from Guatemala to Eliminate 'Dirty Bomb' Risk

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM ... - USA Today